PER 2.50% 8.2¢ percheron therapeutics limited

Very interesting, thanks for this. Having CD49+ as the...

  1. 4,357 Posts.
    lightbulb Created with Sketch. 2033
    Very interesting, thanks for this. Having CD49+ as the biomarker, and not dystrophin will probably aid in any combination trial, or treatment post gene therapy.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.0¢ 8.2¢ 7.9¢ $16.80K 210.0K

Buyers (Bids)

No. Vol. Price($)
1 24999 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 31992 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.